Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Boehringer’s Busy Week – An Acquisition, A Divestiture And A Discontinuation

Executive Summary

Teva’s buyout of Allergan’s generics business should end speculation about a Teva/Mylan merger. A new Sanofi/Regeneron tie-up and an AstraZeneca divestiture to Sanofi’s Genzyme unit are among the latest developments in immuno-oncology.

Advertisement

Related Content

FTC's Generic Market Analysis Forcing Divestures Even In Diverse Categories
Deal Watch: Boehringer’s Busy Week – An Acquisition, A Divestiture And A Discontinuation
Deal Watch: Boehringer’s Busy Week – An Acquisition, A Divestiture And A Discontinuation
Sanofi’s Praluent Closes Gap On Repatha In Europe, As GSK Gets Green Light For World’s First Malaria Vaccine
Jury Still Out On Beta Amyloid Target In Early Alzheimer’s
Germany’s IQWiG Fells AstraZeneca’s Caprelsa Again, Proving Mortality Trumps All
Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS057038

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel